The management of amyotrophic lateral sclerosis.

Hdl Handle:
http://hdl.handle.net/10147/127637
Title:
The management of amyotrophic lateral sclerosis.
Authors:
Phukan, Julie; Hardiman, Orla
Affiliation:
Dept. of Neurology, Beaumont Hospital, and Trinity College Institute of Neuroscience, Dublin 9, Ireland.
Citation:
The management of amyotrophic lateral sclerosis. 2009, 256 (2):176-86 J. Neurol.
Journal:
Journal of neurology
Issue Date:
Feb-2009
URI:
http://hdl.handle.net/10147/127637
DOI:
10.1007/s00415-009-0142-9
PubMed ID:
19224316
Abstract:
The terms amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) refer to a condition characterized by motor system degeneration with relative preservation of other pathways. Although there have been advances in symptomatic treatment, ALS remains an incurable condition. Advances in ALS management prolong survival but simultaneously raise challenging ethical dilemmas for physicians, patients and their families. Here, we review current practice in the management of ALS including pharmacological treatment, nutritional management, respiratory care, and evolving strategies in the management of cognitive impairment.
Item Type:
Article
Language:
en
MeSH:
Amyotrophic Lateral Sclerosis; Caregivers; Cognition Disorders; Genetic Predisposition to Disease; Long-Term Care; Palliative Care; Physician-Patient Relations; Respiration, Artificial; Respiratory Insufficiency; Withholding Treatment
ISSN:
1432-1459

Full metadata record

DC FieldValue Language
dc.contributor.authorPhukan, Julieen
dc.contributor.authorHardiman, Orlaen
dc.date.accessioned2011-04-07T08:54:45Z-
dc.date.available2011-04-07T08:54:45Z-
dc.date.issued2009-02-
dc.identifier.citationThe management of amyotrophic lateral sclerosis. 2009, 256 (2):176-86 J. Neurol.en
dc.identifier.issn1432-1459-
dc.identifier.pmid19224316-
dc.identifier.doi10.1007/s00415-009-0142-9-
dc.identifier.urihttp://hdl.handle.net/10147/127637-
dc.description.abstractThe terms amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) refer to a condition characterized by motor system degeneration with relative preservation of other pathways. Although there have been advances in symptomatic treatment, ALS remains an incurable condition. Advances in ALS management prolong survival but simultaneously raise challenging ethical dilemmas for physicians, patients and their families. Here, we review current practice in the management of ALS including pharmacological treatment, nutritional management, respiratory care, and evolving strategies in the management of cognitive impairment.-
dc.language.isoenen
dc.subject.meshAmyotrophic Lateral Sclerosis-
dc.subject.meshCaregivers-
dc.subject.meshCognition Disorders-
dc.subject.meshGenetic Predisposition to Disease-
dc.subject.meshLong-Term Care-
dc.subject.meshPalliative Care-
dc.subject.meshPhysician-Patient Relations-
dc.subject.meshRespiration, Artificial-
dc.subject.meshRespiratory Insufficiency-
dc.subject.meshWithholding Treatment-
dc.titleThe management of amyotrophic lateral sclerosis.en
dc.typeArticleen
dc.contributor.departmentDept. of Neurology, Beaumont Hospital, and Trinity College Institute of Neuroscience, Dublin 9, Ireland.en
dc.identifier.journalJournal of neurologyen
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.